Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study
<strong>Background</strong> Bisphosphonates are contraindicated in patients with stage 4+ chronic kidney disease. However, they are widely used to prevent fragility fractures in stage 3 chronic kidney disease, despite a lack of good-quality data on their effects. <br> <strong>...
Үндсэн зохиолчид: | Robinson, DE, Ali, MS, Strauss, VY, Elhussein, L, Abrahamsen, B, Arden, NK, Ben-Shlomo, Y, Caskey, F, Cooper, C, Dedman, D, Delmestri, A, Judge, A, Javaid, MK, Prieto-Alhambra, D |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
National Institute for Health Research
2021
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study
-н: Robinson, DE, зэрэг
Хэвлэсэн: (2021) -
Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study
-н: Danielle E Robinson, зэрэг
Хэвлэсэн: (2021-03-01) -
Oral bisphosphonate use and risk of acute kidney injury, gastrointestinal events and hypocalcaemia in patients with moderate-advanced chronic kidney disease: a population-based cohort study
-н: Ali, MS, зэрэг
Хэвлэсэн: (2017) -
Safety of oral bisphosphonates in moderate-to-severe chronic kidney disease: a binational cohort analysis
-н: Robinson, DE, зэрэг
Хэвлэсэн: (2021) -
Bisphosphonates and Age-Related Macular Degeneration: A Propensity-Matched Cohort and Nested Case-Control Analysis
-н: Garriga, C, зэрэг
Хэвлэсэн: (2017)